In other (good) news...

Getting away from the tired Dura Supreme/formaldehyde-in-cabinetry back and forth, I have some good news to report. The BPA advisory panel convened by the FDA has reported that the agency's scientific assessment of the dangers of BPA in regards to human consumption was flawed. The Science Board convened last week to discuss the panel's findings, which included a scathing 17-page review that called the FDA's conclusions on BPA "flawed"--singling out, in particular, the fact that the agency chose to consider only two industry-funded studies showing the chemical to be safe in current dosage guidelines and disregarding more than 200 independent research papers showing the opposite.

More, the FDA is likely going to open the floor to public comments about whether the compound should be taken out of food and beverage containers entirely. From Time Magazine:

But last week, the reviewing panel disagreed, saying the FDA's analysis excluded several important studies on BPA in animals. The panel also questioned the quality of some of the included studies and found that the FDA did not incorporate enough infant-formula samples in its evaluation. According to the panel review, the FDA's safety report "creates a false sense of security" and the agency's margins of safety for BPA exposure are, in fact, "inadequate." Says Tracey Woodruff, director of the program on reproductive health and the environment at the University of California, San Francisco, and a former Environmental Protection Agency scientist: "Unless the evidence is very compelling, you don't get such a strong statement from a group of scientists."